VACCINE VECTOR PLATFORM


Regenica plans to develop a vector platform to generate cutting-edge vaccines to protect against tier-1 select biological threats. This platform has generated potent immunological responses against:

  • Anthrax

  • Tularemia

  • Pneumonic Plague

  • Glanders

  • Melioidosis